Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Receivables - Net: 2022-2025

Historic Receivables - Net for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to $448,990.

  • bioAffinity Technologies' Receivables - Net fell 66.17% to $448,990 in Q3 2025 from the same period last year, while for Sep 2025 it was $448,990, marking a year-over-year decrease of 66.17%. This contributed to the annual value of $1.1 million for FY2024, which is 40.35% up from last year.
  • Per bioAffinity Technologies' latest filing, its Receivables - Net stood at $448,990 for Q3 2025, which was up 6.43% from $421,869 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Receivables - Net registered a high of $1.6 million during Q2 2024, and its lowest value of $9,930 during Q3 2022.
  • Moreover, its 3-year median value for Receivables - Net was $963,744 (2025), whereas its average is $821,960.
  • Its Receivables - Net has fluctuated over the past 5 years, first skyrocketed by 11,062.28% in 2023, then tumbled by 73.56% in 2025.
  • Over the past 4 years, bioAffinity Technologies' Receivables - Net (Quarterly) stood at $10,489 in 2022, then soared by 7,638.34% to $811,674 in 2023, then soared by 40.35% to $1.1 million in 2024, then plummeted by 66.17% to $448,990 in 2025.
  • Its last three reported values are $448,990 in Q3 2025, $421,869 for Q2 2025, and $963,744 during Q1 2025.